Assessment of pulmonary and hematologic
โ
Robert A. Newman; Zahid H. Siddik; Elizabeth L. Travis; David Followill; Workene
๐
Article
๐
1990
๐
Springer US
๐
English
โ 692 KB
The antitumor efficacy as well as hematologic and pulmonary toxicity of Liblomycin, a new lipophilic analog of bleomycin, was evaluated in BDF1 mice. In comparison to bleomycin which was without any antitumor efficacy against P388 leukemia, a dose of 10 mg/kg Liblomycin administered on a daily sched